Today is Independence Day, a time to celebrate and spend cherished time with family and friends. Wishing everyone a happy and safe 4th of July holiday!
ORIC Pharmaceuticals Inc.
Biotechnology Research
South San Francisco, California 5,015 followers
Overcoming Resistance In Cancer
About us
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, (2) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (3) ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens, being developed for multiple myeloma. Beyond these three product candidates, ORIC is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.
- Website
-
https://oricpharma.com/
External link for ORIC Pharmaceuticals Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Type
- Public Company
- Founded
- 2014
- Specialties
- Cancer Resistance, Immunotherapy, and Oncology
Locations
-
Primary
240 E Grand Ave
2nd Floor
South San Francisco, California 94080, US
-
12265 El Camino Real
Suite 370
San Diego , CA 92130, US
Employees at ORIC Pharmaceuticals Inc.
Updates
-
At ORIC, we are committed to making an impact for cancer patients and within our local communities. Recently, ORIC team members proudly volunteered at the SF-Marin Food Bank and San Diego Ronald McDonald House Charities, both charities that strive to make a difference for families in need.
-
The celebration and observance of #Juneteenth is about the journey, achievements and recognition of African Americans. Join us today as we commemorate this important day and acknowledge the important contributions African Americans have made and continue to make to society. Learn more about why we celebrate and the history of Juneteenth here: https://bit.ly/4dJ751R
-
#PRIDEMonth is a celebration that brings people from around the world together to recognize the accomplishments, talents and resilience of the LGBTQIA+ community. At ORIC, we are proud to support our LGBTQIA+ colleagues, industry partners, and patient communities, and acknowledge the strength it takes to live in their truth. We understand that there is power in diversity and inclusion, and we pledge to continue to do our part to create equality for all.
-
ORIC leadership will participate in a fireside chat on June 10th at the Goldman Sachs 45th Annual Global Healthcare Conference. Tune in live at 10:40 am ET to hear Jacob Chacko, M.D., ORIC President and CEO, and Dominic Piscitelli, ORIC CFO, discuss ORIC’s approach to tackling #cancer treatment resistance. The archived replay will be available here: https://bit.ly/3VxP4tj
-
ORIC is looking forward to joining more than 3,000 leading #healthcare executives at this year’s Jefferies Global Healthcare Conference. On June 5th at 10:30 am ET, Jacob Chacko, M.D., ORIC President and CEO, and Dominic Piscitelli, ORIC CFO, will participate in a fireside chat to provide the latest company updates on its mission to overcoming unmet needs in #cancer. Tune in live or view the archived discussion here: https://bit.ly/3VxP4tj
Events & Presentations | ORIC Pharmaceuticals, Inc.
investors.oricpharma.com
-
This National Cancer Survivors Day we celebrate the strength and courage of those who have lived with cancer. While the risk of dying from #cancer has declined, cancer incidences are on the rise, leaving an unmet need for additional treatment options. Learn more about ORIC’s work to develop therapies that address cancer resistance: https://bit.ly/3ARUtUR #NCSD2024 #CelebrateLife
HOME - ORIC Pharmaceuticals
https://oricpharma.com
-
As we celebrate this year's Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Heritage Month, we're proud to raise awareness and honor the #AANHPI community. We're continually uplifted by the remarkable contributions of our #AANHPI colleagues and industry peers, who serve as beacons of innovation and progress in healthcare and life sciences.
-
We kicked off 2024 strong with multiple advancements across both our clinical and preclinical programs. Learn more about our progress and plans for the year here: https://lnkd.in/gDfyDXzg
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates | ORIC Pharmaceuticals, Inc.
investors.oricpharma.com
-
Overcoming resistance in #cancer starts with science and innovation. This #CancerResearch Awareness Month, let's unite in championing groundbreaking research aimed at fulfilling unmet medical needs and transforming the lives of patients. Learn more about our work here: https://bit.ly/3UL950Q #Oncology #Innovation
Patients - ORIC Pharmaceuticals
https://oricpharma.com